European Parliament · 4 May 2022
Discharge in respect of the implementation of the budget of the Innovative Medicines Initiative 2 Joint Undertaking (now the Innovative Health Initiative Joint Undertaking) for the financial year 2020
Adopted
572 in favour · 37 against · 32 abstained. 641 members voted.
What it asks for, in the Parliament's words
- Notes that in 2020 the IMI2 Joint Undertaking’s leverage effect was 1,01
- Notes that the IMI Joint Undertaking utilisation rate for payment appropriations for the Seventh Framework Programme projects was 96 %
Quoted from A9-0072/2022, which says more than these lines. Each is a whole paragraph; this site does not rewrite them.
See how every country and every MEP voted